SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-026868
Filing Date
2024-03-28
Accepted
2024-03-28 07:00:22
Documents
16
Period of Report
2024-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0202788-8k_hoththera.htm   iXBRL 8-K 37423
2 FORM OF NEW WARRANT ea020278801ex4-1_hoththera.htm EX-4.1 104069
3 FORM OF INDUCEMENT LETTER ea020278801ex10-1_hoththera.htm EX-10.1 52154
4 PRESS RELEASE DATED MARCH 27, 2024 ea020278801ex99-1_hoththera.htm EX-99.1 10748
  Complete submission text file 0001213900-24-026868.txt   433527

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hoth-20240327.xsd EX-101.SCH 3039
6 XBRL LABEL FILE hoth-20240327_lab.xml EX-101.LAB 34916
7 XBRL PRESENTATION FILE hoth-20240327_pre.xml EX-101.PRE 22805
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0202788-8k_hoththera_htm.xml XML 3887
Mailing Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 (646)756-2997
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 24793429
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)